Difference between revisions of "I-123 Biomarker Committee"

From QIBA Wiki
Jump to: navigation, search
m (Reference Materials)
m (Recent Meetings/Call Summaries)
Line 8: Line 8:
  
 
==Recent Meetings/Call Summaries==
 
==Recent Meetings/Call Summaries==
 +
 +
*[[Media:2018_11-16_QIBA_SPECT_I-123_Call Summary-FINAL.pdf | November 16, 2018]]
 
*[[Media:2018_08-17_QIBA_SPECT_I-123_Call Summary-FINAL.pdf | August 17, 2018]]
 
*[[Media:2018_08-17_QIBA_SPECT_I-123_Call Summary-FINAL.pdf | August 17, 2018]]
  

Revision as of 19:15, 18 January 2019

Co-chairs: John Dickson, PhD; John Seibyl, MD
Secretary: Julie Lisiecki


Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases

Recent Meetings/Call Summaries

Profile Development

Reference Materials